Innovator Equity Defined Protection ETF 2 Yr to January 2026 (AJAN) 시세

https://www.otcmarkets.com/stock/SDCH/news/SideChannel-Reports-First-Quarter-Results?id=466766

It can't be in halt for this news! That would be ridiculous IMO
https://www.nasdaqtrader.com/trader.aspx?id=tradehalts

Not sure someone brought up the fact that in late January a relabeling or new label was approved which might mean they’re going to market it but we’ll know if we get a PR trying to find out annual volume no information on this product but sounds like depending on if we get a PR or not, they’re just

Spot price....another nothingburger...mulag fedex etc......sanjay....as good as andy

Eventually there will be a need for action taken with the hugely increasing A/S. I suppose it could be a buy back, and the more likely path that will be taken as with most otc's, will be an rs. We'll all find out eventually.

hoping 8x8 for next gen. Ad-tech

3rd paragraph = next generation Ad-tech company
8x8 blows Revvim clear out-of-the-water w/$581-Mil. annual Ad-tech revenue

https://growjo.com/company/Revvim

this would of course be the proverbial 'David & Goliath'

Cancer results $3.85 + 84%

Conspiracy theory…ACCESSWIRE holding off releasing the news so they can load up cheap shares knowing that the news will send the price to new highs.

Also, which ticker is Cohen hinting on instagram is going to 10x? “If you can stack 10k, you can stack 100k. Lock in.” 🤔

wow!!💹100% Xpert SHORT interest✅significant evidence of SHORTS✅💹

Help a pharmaceutical stock newb like me understand the significance here 😅.

White House press secretary says Trump will 'deliver' on Education Dept campaign promise

https://www.youtube.com/watch?v=7IBE1wS5pqw

Interesting thought with EndeavourRx having its own website and they are using that name when attending an upcoming conference to attract institutional investment support, I wonder if they have already done or in process of doing a independent valuation analysis for this division?

The

Traders of this stock are supposed to disregard what is in the company's own print because you try to cast doubt on the messengers motivations. Brilliant. 🙄 It is clear that Mexedia needs this access to the U.S. capital market to serve as a lifeline for what looks on paper to be a failing b

best i can deduce from reading everything is that the settlement is in regards to 'just' the fees owed and the continuing suit is an attempt at clawback on funds paid(?)

Same here, but I understand it would not be livable for a long time there.

That's a personal attack grounds for a report ;)

SideChannel Reports First Quarter Results
Press Release | 02/05/2025
Financial results conference call on Wednesday, February 5 @ 4:30 P.M. ET

WORCESTER, MA / ACCESS Newswire / February 5, 2025 / SideChannel, Inc. (OTCQB:SDCH) ("SideChannel"), a leading provider of cyber

BEST SELLERS RANK (BSR) IS 578 33 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec

💹Xplosive ShortFilm incoming✅$AMC Silver investments Golden💹huzzah

".....fire.....fire works.......believe it...."
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif

Lol. Good one!

$GOOGL $GOOG Alphabet price target changes:

to $210 from $215 at Morgan Stanley
to $209 from $211 at UBS
to $229 from $232 at Citi
to $220 from $232 at JPMorgan
to $208 from $210 at Piper Sandler
to $220 from $225 at KeyBanc

Stop stealing Act https://x.com/realdogeusa/status/1886871878083731523?s=42

If $190s don't hold then market correction would eventually have it settle at $170